Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER.
Lars SavendahlMichel PolakPhilippe BackeljauwJoanne C BlairBradley S MillerTilman R RohrerAnita Hokken-KoelegaAlberto PietropoliNicky KelepourisJudith RossPublished in: The Journal of clinical endocrinology and metabolism (2021)
We observed no indication of increased mortality risk nor AE incidence related to GH dose in any risk group. A short visual summary of our work is available (1).
Keyphrases